N-(2-(4'-cyanobiphenyl-4-yl)propyl)propane-2-sulfonaMide
- Product Name
- N-(2-(4'-cyanobiphenyl-4-yl)propyl)propane-2-sulfonaMide
- CAS No.
- 211311-95-4
- Chemical Name
- N-(2-(4'-cyanobiphenyl-4-yl)propyl)propane-2-sulfonaMide
- Synonyms
- 100775;CS-2739;LY40418;LY404187;LY-404187; LY 404187;LY-404187, 10 mM in DMSO;N-2-(4-(4-Cyanophenyl)phenyl)propyl-2-propanesulfonamide;N-(2-(4'-cyanobiphenyl-4-yl)propyl)propane-2-sulfonamide;N-(2-(4'-cyanobiphenyl-4-yl)propyl)propane-2-sulfonamide;N-[2-[4-(4-Cyanophenyl)phenyl]propyl]propane-2-sulfonamide
- CBNumber
- CB42640286
- Molecular Formula
- C19H22N2O2S
- Formula Weight
- 342.46
- MOL File
- 211311-95-4.mol
N-(2-(4'-cyanobiphenyl-4-yl)propyl)propane-2-sulfonaMide Property
- Boiling point:
- 519.0±60.0 °C(Predicted)
- Density
- 1.19±0.1 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- solubility
- DMF: 15mg/mL; DMSO: 15mg/mL; DMSO:PBS (pH 7.2) (1:4): 0.2mg/mL; Ethanol: 3mg/mL
- form
- A solid
- pka
- 11.24±0.40(Predicted)
- color
- White to off-white
N-Bromosuccinimide Price
- Product number
- 28741
- Product name
- LY404187
- Packaging
- 5mg
- Price
- $110
- Updated
- 2024/03/01
- Product number
- 28741
- Product name
- LY404187
- Packaging
- 50mg
- Price
- $542
- Updated
- 2024/03/01
- Product number
- 28741
- Product name
- LY404187
- Packaging
- 10mg
- Price
- $175
- Updated
- 2024/03/01
- Product number
- 28741
- Product name
- LY404187
- Packaging
- 25mg
- Price
- $352
- Updated
- 2024/03/01
- Product number
- 5297
- Product name
- LY404187
- Purity
- ≥98%(HPLC)
- Packaging
- 10
- Price
- $210
- Updated
- 2021/12/16
N-(2-(4'-cyanobiphenyl-4-yl)propyl)propane-2-sulfonaMide Chemical Properties,Usage,Production
Description
LY404187 is a benzothiadiazide positive allosteric modulator of AMPA receptors. It increases glutamate-induced activation of GluR1i, -2i, -2o, -3i, and -4i subunit-containing AMPA receptors with EC50 values of 5.65, 0.15, 1.44, 1.66, and 0.21 μM, respectively, in a calcium influx assay. LY404187 is selective for these AMPA receptors over GluR6 subunit-containing kainate receptors at 10 μM. LY404187 increases currents induced by glutamate and AMPA in rat prefrontal cortex pyramidal neurons (EC50s = 1.3 and 1.2 μM, respectively) but not in AMPA-stimulated primary rat embryonic hippocampal or primary cerebellar Purkinje neurons. LY404187 prevents decreases in the number of dopaminergic neurons in the substantia nigra induced by MPTP and 6-OHDA in mouse and rat, respectively, models of Parkinson’s disease when administered at a dose of 0.5 mg/kg per day.
Uses
LY 404187 is a novel positive allosteric modulator of AMPA receptors.
in vivo
LY-404187 (0.5 mg/kg; s.c for 11 days) can prevent MPTP-induced neurotoxicity in mice[4].
LY-404187 (0.5 mg/kg; s.c. for 28 days) attenuates apomorphine-induced contraversive rotations and affords significant protection against the loss of tyrosine hydroxylase positive nigral cell bodies[4].
LY-404187 (0.1 or 0.5 mg/kg; s.c. for 14 days) affords functional, neurochemical and histological protection after infusion of 6-hydroxydopamine into the substantia nigra in rats[4].
LY-404187 (0.5 mg/kg; s.c. for 14 days) delayed treatment provides functional and histological improvement, suggesting a trophic action as administration is initiated after cell death[4].
LY-404187 (0.1 and 0.5 mg/kg; s.c. for 14 days) increases GAP-43 immunoreactivity in the striatum in a dose-dependent manner[4].
| Animal Model: | Male C57BL/6J mice (20-25 g) are challenged with MPTP on day 8[4] |
| Dosage: | 0.5 mg/kg |
| Administration: | S.c; twice daily on weekdays and once daily at weekends for 11 days |
| Result: | Attenuated the loss of tyrosine hydroxylase immunoreactivity in the substantia nigra. No significant change in tyrosine hydroxylase immunoreactivity in the dorsal and ventral striatum. |
storage
Store at +4°C
References
[1] P MIU . Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro[J]. Neuropharmacology, 2001, 40 8: Pages 976-983. DOI: 10.1016/s0028-3908(01)00027-2
[2] De Souza, F.I., Zumiotti, A.V., and Da Silva, C.F. Neuregulins 1-α and 1-β on the regeneration the peripheral nerves[J]. Acta Ortop Bras.
[3] M GATES D B A Ogden. Pharmacological effects of AMPA receptor potentiators LY392098 and LY404187 on rat neuronal AMPA receptors in vitro[J]. Neuropharmacology, 2001, 40 8: Pages 984-991. DOI: 10.1016/s0028-3908(01)00040-5
[4] MICHAEL J O’NEILL . Neurotrophic actions of the novel AMPA receptor potentiator, LY404187, in rodent models of Parkinson’s disease[J]. European journal of pharmacology, 2004, 486 2: Pages 163-174. DOI: 10.1016/j.ejphar.2003.12.023
N-(2-(4'-cyanobiphenyl-4-yl)propyl)propane-2-sulfonaMide Preparation Products And Raw materials
Raw materials
Preparation Products
N-(2-(4'-cyanobiphenyl-4-yl)propyl)propane-2-sulfonaMide Suppliers
- Tel
- Fax
- 86-21-57758967
- sales@boylechem.com
- Country
- China
- ProdList
- 2922
- Advantage
- 55
- Tel
- 0510-83588313-811 18800520310
- sales@chemshuttle.com
- Country
- China
- ProdList
- 2999
- Advantage
- 62
- Tel
- +1 (866) 930-6790
- Fax
- +1 (866) 333-9607
- info@adooq.com
- Country
- United States
- ProdList
- 2782
- Advantage
- 58
- Tel
- Mobile:13665161512
- Fax
- +86-510-68873513
- Country
- China
- ProdList
- 1785
- Advantage
- 58
- Tel
- 021-61478794
- Fax
- 021-61478794
- sales@hcshhai.com
- Country
- China
- ProdList
- 9793
- Advantage
- 50
- Tel
- 13391076197
- tombiopharma@163.com
- Country
- China
- ProdList
- 4987
- Advantage
- 55
- Tel
- 025-58849295 18951903616;
- Fax
- 025-68650336
- info@adooq.cn
- Country
- China
- ProdList
- 2990
- Advantage
- 60
- Tel
- +86-21-5821 5861
- Fax
- +86-21-5106 2861
- sales@letopharm.com
- Country
- China
- ProdList
- 2384
- Advantage
- 58
- Tel
- 021-52996696,15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4757
- Advantage
- 55
- Tel
- 027-59207879 1972026995 18140587686
- Fax
- QQ:1972026995
- sales@3600chem.com
- Country
- China
- ProdList
- 4456
- Advantage
- 55